Zobrazeno 1 - 10
of 19
pro vyhledávání: '"OPAL Rheumatology"'
Autor:
Sabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, Kathryn A. Gibson, Ewa Haladyj, Peter Youssef, Paul Bird, Catherine O'Sullivan, Tegan Smith, Claire T. Deakin, OPAL Rheumatology
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 7, Pp 345-353 (2023)
Objective To analyze comparative treatment persistence for first‐line baricitinib (BARI) versus first‐line tumor necrosis factor inhibitor (TNFi) in patients with rheumatoid arthritis (RA) and for first‐line BARI initiated as monotherapy versus
Externí odkaz:
https://doaj.org/article/4d2c347dcd0d4556b637deb60b95cc9a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deakin, Claire T, De Stavola, Bianca L, Littlejohn, Geoffrey, Griffiths, Hedley, Ciciriello, Sabina, Youssef, Peter, Mathers, David, Bird, Paul, Smith, Tegan, O'Sullivan, Catherine, Freeman, Tim, Segelov, Dana, Hoffman, David, Seaman, Shaun R, OPAL Rheumatology Network
IMPORTANCE: There is a need for observational studies to supplement evidence from clinical trials, and the target trial emulation (TTE) framework can help avoid biases that can be introduced when treatments are compared crudely using observational da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______109::79a4cdbff9a682fda1f3b5a3dc730a6b
https://www.repository.cam.ac.uk/handle/1810/353480
https://www.repository.cam.ac.uk/handle/1810/353480
Autor:
Ciciriello S; OPAL Rheumatology Ltd, Sydney, NSW; and Royal Melbourne Hospital, Melbourne, VIC, Australia., Littlejohn GO; OPAL Rheumatology Ltd, Sydney, NSW; and Department of Medicine, Monash University, Clayton, VIC, Australia. geoff.littlejohn@monash.edu., Treuer T; Eli Lilly and Company, Indianapolis, IN, USA., Gibson KA; Eli Lilly and Company, Indianapolis, IN, USA; Liverpool Hospital, Liverpool, NSW; and University of New South Wales, Kensington, NSW, Australia., Haladyj E; Eli Lilly and Company, Indianapolis, IN, USA., Youssef P; OPAL Rheumatology Ltd, Sydney, NSW; Royal Prince Alfred Hospital, Sydney, NSW; and University of Sydney, NSW, Australia., Bird P; OPAL Rheumatology Ltd, Sydney, NSW; and University of New South Wales, Kensington, NSW, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Deakin CT; OPAL Rheumatology Ltd, Sydney, NSW, Australia; Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals, Great Ormond Street Hospital and University College London; and National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK.
Publikováno v:
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Sep; Vol. 42 (9), pp. 1763-1772. Date of Electronic Publication: 2024 May 01.
Autor:
Littlejohn G; OPAL Rheumatology Ltd, Sydney, NSW, Australia. geoff.littlejohn@monash.edu.; Monash University, Clayton, VIC, Australia. geoff.littlejohn@monash.edu.; Suite H, Monash Medical Centre, Clayton, VIC, 3168, Australia. geoff.littlejohn@monash.edu., Anbumurali N; OPAL Rheumatology Ltd, Sydney, NSW, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Tymms K; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; Canberra Rheumatology, Canberra, ACT, Australia., Bird P; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; University of New South Wales, Kensington, Australia.; Emeritus Research, Botany, NSW, Australia., Nicholls D; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; Coast Joint Care and University of The Sunshine Coast, Maroochydore, QLD, Australia., Griffiths H; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; Barwon Rheumatology, Geelong, VIC, Australia.
Publikováno v:
Clinical rheumatology [Clin Rheumatol] 2024 Jun; Vol. 43 (6), pp. 1823-1832. Date of Electronic Publication: 2024 Apr 18.
Autor:
Littlejohn G; OPAL Rheumatology Ltd, Sydney, NSW, Australia. geoff.littlejohn@monash.edu.; Departments of Medicine, Monash Medical Centre, Monash University and Rheumatology, Monash Health, Clayton, VIC, 3168, Australia. geoff.littlejohn@monash.edu., Leadbetter J; WriteSource Medical Pty Ltd, Lane Cove, New South Wales, Australia., Butcher BE; WriteSource Medical Pty Ltd, Lane Cove, New South Wales, Australia.; School of Biomedical Sciences, University of New South Wales, Kensington, NSW, Australia., Feletar M; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; Rheumatology, Dandenong, VIC, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, NSW, Australia., Witcombe D; Pfizer Australia, Sydney, NSW, Australia., Ng HY; Pfizer Australia, Sydney, NSW, Australia., Youssef P; OPAL Rheumatology Ltd, Sydney, NSW, Australia.; Institute of Musculoskeletal Health at University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Publikováno v:
Clinical rheumatology [Clin Rheumatol] 2024 May; Vol. 43 (5), pp. 1579-1589. Date of Electronic Publication: 2024 Mar 09.
Autor:
Deakin CT; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; Centre for Adolescent Rheumatology at University College London, University College London Hospitals and Great Ormond Street Hospital, London, UK.; National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK., Littlejohn GO; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; Department of Medicine, Monash University, Melbourne, Victoria, Australia., Griffiths H; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; Barwon Rheumatology Service, Geelong, Victoria, Australia., Ciciriello S; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; Royal Melbourne Hospital, Melbourne, Victoria, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Youssef P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Bird P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; Department of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Publikováno v:
Internal medicine journal [Intern Med J] 2024 May; Vol. 54 (5), pp. 795-801. Date of Electronic Publication: 2023 Nov 27.
Autor:
Ciciriello S; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Littlejohn G; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Department of Medicine, Monash University, VIC, Clayton, Australia., O'Sullivan C; OPAL Rheumatology Ltd., Sydney, NSW, Australia. cath.osullivan@opalrheumatology.com.au., Smith T; OPAL Rheumatology Ltd., Sydney, NSW, Australia., Deakin CT; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals and Great Ormond Street Hospital, London, UK.; National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK.
Publikováno v:
Clinical rheumatology [Clin Rheumatol] 2023 Nov; Vol. 42 (11), pp. 2971-2980. Date of Electronic Publication: 2023 Jul 05.
Autor:
Ciciriello S; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and The Royal Melbourne Hospital Melbourne, Victoria, Australia., Littlejohn G; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and Monash University, Clayton, Victoria, Australia., Treuer T; Eli Lilly and Company, Indianapolis, Indiana., Gibson KA; Eli Lilly and Company, Indianapolis, Indiana, Liverpool Hospital, Liverpool, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia., Haladyj E; Eli Lilly and Company, Indianapolis, Indiana., Youssef P; OPAL Rheumatology Ltd, Royal Prince Albert Hospital, and University of Sydney, Sydney, New South Wales, Australia., Bird P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Deakin CT; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals, Great Ormond Street Hospital and University College London, and National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK.
Publikováno v:
ACR open rheumatology [ACR Open Rheumatol] 2023 Jul; Vol. 5 (7), pp. 345-353. Date of Electronic Publication: 2023 Jun 12.
Autor:
Tymms K; Canberra Rheumatology, Canberra, ACT, Australia., O'Sullivan C; OPAL Rheumatology, Sydney, NSW, Australia., Smith T; OPAL Rheumatology, Sydney, NSW, Australia., Littlejohn G; OPAL Rheumatology, Sydney, NSW, Australia.; Monash University, Clayton, VIC, Australia., Freeman T; Software4Specialists Pty Ltd, Sydney, NSW, Australia., Hoffman D; Software4Specialists Pty Ltd, Sydney, NSW, Australia., Segelov D; Software4Specialists Pty Ltd, Sydney, NSW, Australia., Griffiths H; OPAL Rheumatology, Sydney, NSW, Australia.; Barwon Rheumatology Service, Geelong, VIC, Australia., Ciciriello S; OPAL Rheumatology, Sydney, NSW, Australia.; Royal Melbourne Hospital, Parkville, VIC, Australia., Youssef P; OPAL Rheumatology, Sydney, NSW, Australia.; University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred, Camperdown, NSW, Australia., Mathers D; OPAL Rheumatology, Sydney, NSW, Australia.; Georgetown Arthritis, Newcastle, NSW, Australia., Deakin CT; OPAL Rheumatology, Sydney, NSW, Australia.
Publikováno v:
Frontiers in digital health [Front Digit Health] 2023 Jan 09; Vol. 4, pp. 1074931. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).